Thabut Dominique, Massard Julien, Gangloff Alice, Carbonell Nicolas, Francoz Claire, Nguyen-Khac Eric, Duhamel Christian, Lebrec Didier, Poynard Thierry, Moreau Richard
AP-HP Service d'Hépato-Gastroentérologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Hepatology. 2007 Dec;46(6):1872-82. doi: 10.1002/hep.21920.
Although it is often functional at presentation, acute renal failure has a poor prognosis in patients with cirrhosis. The role of inflammation, a key event in the outcome of cirrhosis, has never been studied in this setting. We aimed to investigate the predictive factors of mortality in patients with cirrhosis and acute functional renal failure, specifically in relation to inflammatory events. One hundred consecutive patients with cirrhosis from 5 French hospitals were prospectively included at the day of onset of acute renal failure. Medical history, treatments, and procedures during the month before inclusion were recorded. Physical examination, blood and urinary chemistries, and renal ultrasound examination were performed. The presence of systemic inflammatory response syndrome (SIRS), infection, and sepsis was assessed. The primary outcome was in-hospital mortality. The mechanism of renal failure was functional in 83 patients. Causes of renal failure were hypovolemia (34%), hepatorenal syndrome without ongoing infection (17%), hepatorenal syndrome with ongoing infection (16%), nephrotoxicity (2%), and multifactorial (31%). SIRS was observed in 41% of patients, 56% of them with infection. In-hospital mortality was 68% in patients with SIRS and 33% in patients without (P = 0.001). In multivariate analysis, only model for end-stage liver disease score and presence of SIRS, but not infection, remained associated with a poor outcome.
The presence of SIRS, with or without infection, is a major independent prognostic factor in patients with cirrhosis and acute functional renal failure. This suggests that preventing and treating SIRS could decrease mortality in patients with cirrhosis and acute renal failure.
尽管急性肾衰竭在出现时通常具有功能异常,但肝硬化患者的急性肾衰竭预后较差。炎症作为肝硬化预后的关键事件,在这种情况下从未被研究过。我们旨在调查肝硬化合并急性功能性肾衰竭患者的死亡预测因素,特别是与炎症事件相关的因素。来自5家法国医院的100例连续肝硬化患者在急性肾衰竭发作当天被前瞻性纳入研究。记录入组前一个月的病史、治疗和操作情况。进行体格检查、血液和尿液化学检查以及肾脏超声检查。评估全身炎症反应综合征(SIRS)、感染和脓毒症的存在情况。主要结局是住院死亡率。83例患者肾衰竭的机制为功能性。肾衰竭的原因包括血容量不足(34%)、无持续感染的肝肾综合征(17%)、有持续感染的肝肾综合征(16%)、肾毒性(2%)和多因素(31%)。41%的患者观察到SIRS,其中56%伴有感染。SIRS患者的住院死亡率为68%,无SIRS患者为33%(P = 0.001)。在多变量分析中,只有终末期肝病模型评分和SIRS的存在与不良结局相关,而感染无关。
无论有无感染,SIRS的存在是肝硬化合并急性功能性肾衰竭患者的主要独立预后因素。这表明预防和治疗SIRS可降低肝硬化合并急性肾衰竭患者的死亡率。